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Abstract
Background: The fully differentiated progeny of ES cells (ESC) may eventually be used for cell replacement therapy (CRT).
However, elements of the innate immune system may contribute to damage or destruction of these tissues when
transplanted.
Methodology/Principal Findings: Herein, we assessed the hitherto ill-defined contribution of the early innate immune
response in CRT after transplantation of either ESC derived insulin producing cell clusters (IPCCs) or adult pancreatic islets.
Ingress of neutrophil or macrophage cells was noted immediately at the site of IPCC transplantation, but this infiltration was
attenuated by day three. Gene profiling identified specific inflammatory cytokines and chemokines that were either absent
or sharply reduced by three days after IPCC transplantation. Thus, IPCC transplantation provoked less of an early immune
response than pancreatic islet transplantation.
Conclusions/Significance: Our study offers insights into the characteristics of the immune response of an ESC derived tissue
in the incipient stages following transplantation and suggests potential strategies to inhibit cell damage to ensure their
long-term perpetuation and functionality in CRT.
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Introduction
The capacity of embryonic stem cells (ESC) to form multiple
tissue types has fuelled hope that they may eventually be used to
provide an alternative or supplementary supply of tissue for cell
replacement therapy (CRT) in diseases that lead to organ
degeneration or failure, such as Type 1 diabetes mellitus [1].
However, the host immune response invoked following transplan-
tation of ESC derived tissue presents a potential impediment to
their therapeutic use [2,3].
Use of an ESC derived tissue in CRT may be limited by a
number of generic events that impinge on the functionality of
transplanted tissue. Firstly, any episode inducing tissue damage,
such as the process of transplantation, will elicit an early
inflammatory response, even in the syngeneic setting [4,5]. While
this complex, multi-factorial response to injury has evolved to
protect the host against pathogens, rejuvenate damaged tissue and
restore homeostasis, acute inflammation could be damaging to
transplanted tissue and may be a crucial factor in determining
optimum graft functionality; this issue has been hypothesized to be
of importance in graft function in islet transplantation [6,7].
Secondly, an early inflammatory response may provide the
foundation for activation of an antigen specific, adaptive immune
response in an allograft setting [8]. In this respect, mounting
evidence suggests the adaptive immune response may be invoked
as a direct corollary of an inflammatory response [9]. Thus, in
addition to the potential damage to transplanted tissue caused by
inflammation, the early immune events after transplantation may
also impact rejection of transplanted tissue in the longer term.
Studies hitherto have almost exclusively focused on the adaptive
immune response toward ESC or ESC derived allografts [10,11,12]
and the early immune response towards transplanted ESC derived
tissue has largely been neglected. In addition, an assessment of
the immunogenicity of terminally differentiated ESC products has
been lacking; this is a critical issue as undifferentiated ESC and
terminally differentiated ESC progeny can exhibit differing
immunogenicity [2,13]. By comparing the immune response
following either implantation of ESC derived insulin producing
cell clusters (IPCC) or adult pancreatic islets of Langerhans, we
have therefore assessed the early immune response to fully
differentiated ESC tissue during the first three days following
transplantation of either syngeneic or allogeneic tissue.
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Materials and Methods
ESC culture and differentiation to insulin producing cell
clusters (IPCCs)
The ESC line ESF 122 was maintained as described
previously[1]. Briefly, ESC were plated onto mitotically inactivat-
ed primary embryonic fibroblasts (3000 rad) in ESC medium
composed of knock-out (KO-) DMEM (Invitrogen, Paisley,
Scotland), 15% FCS, 1% 100 mM L-glutamine, 1% non-essential
amino acids (non-eAAs) (all Invitrogen), 1% 100 mM penicillin-
streptomycin, 100 mM b-ME and 100 ml/10ml medium 10 mg/ml
LIF (Chemicon International, Temecula, California, USA).
Directed differentiation of ESC was achieved using a modified
form of the Blyszczuk protocol as described previously [1]. See
Supplemental Figure S1 for further details.
Animals
7-12 week old female syngeneic CBA or allogeneic C57 BL/10
mice were obtained from and housed within the Biomedical
Services Unit (BMSU) of the John Radcliffe Hospital (Oxford,
UK).
Ethics Statement
The ESC line ESF 122 was generated as described previously
[1]. Mice were maintained ad libitum on sterilised food and water in
accordance with the animal care and use guidelines approved by
the Home Office (London, UK).
Isolation of adult pancreatic islets
Adult pancreatic islets were isolated as described previously [1].
Briefly, islets were isolated by collagenase digestion of the
pancreas, followed by centrifugation through a discontinuous
Ficoll gradient.
Transplantation of IPCCs or pancreatic islets
Transplantation of IPCCs or pancreatic islets was performed as
described previously [1]. Briefly, 300 IPCCs or pancreatic islets
were transplanted under the sub-capsular renal space of an
anesthetized mouse. ‘Sham’ transplantation was performed as a
control for the non-specific inflammation induced by the surgical
procedure itself; the recipients received no cells, but underwent the
surgical procedure: the abdomen of each anesthetized mouse was
opened, the kidney exposed and an incision made in the kidney
capsule. Post-transplant, vicryl sutures were used to close the
peritoneum and the skin of all transplanted recipients.
Immunofluorescence
Islet and IPCC subcapsular kidney grafts were harvested,
embedded in OCT Tissue-Tek (Miles Diagnostics, Elkhart, IN,
USA) compound. 6 mm sections were air dried and then fixed in
acetone. Non-specific binding was blocked with PBS/10% FCS
or PBS/4% mouse, goat or rabbit serum, depending on the
primary antibody used, prior to primary antibody staining with
Gr-1, Mac-1 or C3. Following secondary antibody staining, the
sections were mounted with Vectashield mounting medium with
49, 6-diamino-2-phenylindole (DAPI) (Vector Labs, UK) and
visualized with a Zeiss Fluorescence microscope using Openlab
4.0.1 software.
Quantitative real-time PCR
RNA and cDNA preparation was performed as described
previously [1]. Briefly, total cellular RNA was isolated from
undifferentiated ES cells, end-stage IPCCs, pancreas, islets and
spleen using the Stratagene Absolutely RNATM kit. 2ng of RNA,
was reverse transcribed into cDNA with Moloney Murine
Leukaemia Virus (MMLV)-reverse transcriptase (MMLV-RT,
Invitrogen) according to the manufacturers instructions. 2.5ng of
template was used and for each sample PCR was performed in
duplicate or triplicate. PCR primer sets used in this study have
been previously validated and sequences are provided in
Supplemental Table S1 and S2 [4,14]. Quantitation was
performed by standard methods described previously [15].
Statistical analysis
Cellular infiltration and PCR data were subjected to statistical
analyses. The paired, 2-tailed Student t test was used to compare
two biologically paired samples transplanted under the same
conditions into age and sex matched recipients
Results
Experimental model
We have previously compared multiple methods for the
differentiation of ESC to IPCCs and confirmed the fully
differentiated status of IPCCs [1,13]. By using a modified
protocol for ESC differentiation to IPCCs derived from
Blyszczuk et al [1,16] (Supplemental Figure S1), we now
assess the early immune events that follow transplantation of
IPCCs derived from ESF 122 ESC (H2k) or adult pancreatic
islets isolated from CBA mice (H2k) [1,2,13] (Supplemental
Figure S2). The immune response to transplanted tissue was
evaluated in a non-diabetic mouse background to avoid the
confounding contribution of the autoimmunity observed in
diabetic mice or mice with chemically induced diabetes in vivo.
Three hundred IPCCs or adult pancreatic islets were transplant-
ed under the kidney capsule of syngeneic (CBA) or allogeneic
(C57 BL/10, H2b) recipient mice and the graft was excised 1 or 3
days later. Half of the kidney containing the transplanted cells
was reserved for immunofluorescence staining and histological
examination, while the other half was analysed by quantitative
real-time PCR (Q-PCR) analysis of gene expression. Importantly,
‘sham’ transplantation was performed as a control for the non-
specific inflammation caused by the surgical procedure used for
tissue implantation. Assessing immune cell infiltration or relative
gene expression against ‘sham’ transplant controls therefore
affords a more accurate assessment of the immune response
induced specifically by transplantation of syngeneic versus
allogeneic IPCC tissue.
IPCC allografts are less prone to infiltration by innate
immune cells early after transplantation
We firstly examined innate leukocyte infiltration to the IPCCs
or islet in the initial stages after transplantation. In comparison to
‘sham’ transplant controls, neither syngeneic IPCCs or syngeneic
adult islets induced infiltration of Gr1+ cells within the first 24
hours after implantation (Figure 1A, 1B and 1C; for positive
controls see Supplemental Figure S3). However, at the same
time point, the number of Gr1+ cells infiltrating was noticeably
higher in allogeneic IPCC grafts compared with both syngeneic
transplants and sham control transplants (Figure 1A and 1C).
Compared to either syngeneic islet grafts or the ‘sham’
transplantation at day 1 and 3, a significant Gr1+ infiltrate was
noted at the site of implantation of allogeneic islet grafts
(Figure 1B and 1C). These data show that the early infiltration
of Gr-1+ cells occurs exclusively in the setting of allogeneic IPCC
or islet transplantation. Of interest, however, IPCC allografts were
infiltrated by Gr-1+ cells to a lesser extent than islet allografts at
Innate Immune Response to ESCs
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three days after transplantation, showing that ES cell derived
IPCCs may be less to susceptible to immune attack by neutrophils
than adult islet tissue (Figure 1C).
Monocyte/macrophage infiltration, as judged by CD11b
staining, was comparable between ‘sham’ transplanted and IPCC
syngeneic or allogeneic graft sites at day 1 (Figure 2A and 2C).
On day 3, however, both the syngeneic and allogeneic grafts were
infiltrated by Mac-1+ cells above levels observed in ‘sham’ controls
and the abundance of infiltrating cells was similar in each case
(Figure 2A and 2C). Likewise, a similar degree of infiltration by
CD11b+ cells was noted in syngeneic and allogeneic islet grafts and
‘sham’ transplanted animals at day 1 (Figure 2B and 2C).
Figure 1. IPCC allografts are less prone to neutrophil infiltration early after transplantation. (A) 300 IPCCs generated from CBA-derived
ES cells or (B) 300 adult pancreatic islets were transplanted under the kidney capsule of syngeneic (CBA, H2k) or allogeneic (C57 BL/10, H2b) recipient
mice and the graft harvested either on day 1 or 3 days post-transplant. Sections were stained for the granulocyte marker Gr1/Ly6G (FITC, green) and
counterstained with the DAPI nuclear-dye (blue) (n = 4 experiments). Sham transplantations were also performed (data not shown). The spleen served
as positive staining control (Supplemental Figure 3). Photographs were taken using a 40x objective and a 10x eyepiece lens, giving a total original
magnification of6400. (C) The number of Gr1+ cells infiltrating IPCC grafts or islet grafts was quantified by counting the number of green cells in 5
high power fields per sample (n = 426 independent samples/time point from independent differentiations). A naı¨ve kidney was harvested from an
un-manipulated mouse as a negative control for Gr1+ cells within the kidney at day 0 (striped bar). Data shown are the mean 6 SEM and statistical
significance was assessed by unpaired Student’s t test and denoted by an asterisk in the figure.
doi:10.1371/journal.pone.0010965.g001
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However, by day 3 islet grafts provoked an increased degree (2-
fold) of infiltration by CDl1b+ cells than the ‘sham’ control
(Figure 2B and 2C). As observed for infiltration of Gr1+ cells,
IPCC allografts were infiltrated by fewer CD11b+ cells than islet
allografts at three days after transplantation (compare
Figures 1C and 2C).
Figure 2. Attenuated influx ofmacrophages to IPCC allografts early after transplantation. (A) 300 IPCCs generated from CBA-derived ES cells
or (B) 300 adult pancreatic islets were transplanted under the kidney capsule of syngeneic (CBA, H2k) or allogeneic (C57 BL/10, H2b) recipient mice and the
graft harvested either on day 1 or 3 days post-transplant. Sections were stained for the granulocyte marker Mac-1/CD11b (red) and counterstained with
the DAPI nuclear-dye (blue) (n= 4 experiments). (data not shown). Sham transplantations were also performed (data not shown). The spleen served as
positive staining control (Supplemental Figure 3). Photographs were taken using a 40x objective and a 10x eyepiece lens, giving a total original
magnification of6400. (C) The number of Mac-1+ cells infiltrating IPCC grafts or adult islet grafts was quantified by counting the number of green cells in 5
high power fields per sample (n=426 independent samples/time point frommultiple independent differentiations). A naı¨ve un-transplanted kidney was
harvested from an un-manipulated mouse as a control to represent the baseline level of Mac-1+ cells within the kidney at day 0 (striped bar). Data shown
are the mean 6 SEM and statistical significance was assessed by unpaired Student’s t test and denoted by an asterisk in the figure.
doi:10.1371/journal.pone.0010965.g002
Innate Immune Response to ESCs
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Jointly these data indicate that in the first 3 days following
implantation innate immune cells can infiltrate the graft site as a
specific response to the presence of the transplanted IPCCs and
across allogeneic barriers. Intriguingly, however, these data
demonstrate that at this early time after transplantation, IPCC
allografts are less prone to infiltration by innate immune cells than
islet allografts.
Attenuated infiltration of innate immune cells across
IPCC allogeneic barriers was independent of
complement deposition
The previous data indicates that activation of the innate
immune system occurs after transplantation of IPCCs across
allogeneic barriers, albeit to a lesser extent than in islets. Since
the complement system is a critical bridge between the innate and
adaptive immune responses [17], we next chose to examine
whether the complement molecule C3, a molecule central to the
activation of all 3 complement pathway cascades, was detectable
in IPCC or islet transplanted recipients. Figure 3A shows
sections of IPCC engrafted kidney staining strongly for C3 in
both syngeneic and allogeneic groups; C3 was observed in
sections excised 1 day after transplant and a robust C3 signal was
retained on day 3. The transplanted islet samples (Figure 3B)
demonstrated a similar strength signal and expression pattern of
C3 in comparison to IPCC on day 1 until day 3 post-transplant
sections. Of particular note, examination of the structure of the
kidney versus grafted tissue demonstrated that C3 was bound
indiscriminately throughout the kidney, with no differences
observed between sample types. Interestingly, the ‘sham’
transplantation showed similar staining for C3 compared to
either islets or IPCCs in a syngeneic or allogeneic background
(Figure 3A and B). Taken together, these data show that
complement activation resulting in the production of complement
fragments that bind covalently to IPCCs or islets occurs
regardless of the presence of the transplanted tissue itself. These
data also imply that attenuated infiltration of innate immune cells
across IPCC allogeneic barriers occurs independently of comple-
ment activation.
Marked reduction in IL-6 at the early stages following
IPCC transplantation
As early inflammation at the site of transplantation can lead to
the generation and release of chemical mediators, such as
cytokines [18], we assessed the production of inflammatory
cytokines IL-6 and TNF-a after transplantation of IPCCs or islets
into syngeneic or allogeneic recipients by Q-PCR. When IL-6
mRNA expression was analysed at 3 days after transplantation, a
100 and 10000 fold increase in IL-6 mRNA expression was noted
in syngeneic and allogeneic islet samples respectively. Importantly,
IL-6 mRNA was not up-regulated by day 3 in either IPCC
syngeneic grafts or allografts when compared to ‘sham’ transplan-
tation (Figure 4). In contrast, TNF-a expression was not observed
in the early immune response to either IPCC or islet transplan-
tation (data not shown). Ergo, in contrast to islet transplanta-
tion, IL-6 mRNA was not produced specifically as an early
inflammatory response to IPCC transplantation.
Attenuated inflammatory chemokine expression
immediately following IPCC transplantation
Inflamed transplanted tissues can themselves produce an ‘early’
wave of chemokines, including Gro-b/CXCL2, Lix/CXCL5,
MCP-1/CCL2, MIP-1a/CCL3 and MIP-1b/CCL4, which can
mediate the migration of immune cells to the site of tissue damage
or injury [9,19]. By Q-PCR, we next examined the expression of
these chemokines up to three days following IPCC or islet
transplantation. After IPCC transplantation, MCP-1/CCL2,
MIP-1a/CCL3 and MIP-1b/CCL4 mRNA were induced above
the level detected in the ‘sham’ transplantation controls at day 1,
indicating that IPCCs specifically induce these chemokines
immediately after transplantation (Figure 5C-5E). Excepting
the lack of induction of MIP-1b/CCL4 in islet syngeneic and
allogeneic grafts, these results were broadly comparable to those
obtained following transplantation of islets into syngeneic or
allogeneic mice at day 1 (Figure 5E). At day 3, weak or no
induction of Gro-b/CXCL2, MCP-1/CCL2, MIP-1a/CCL3 and
MIP-1b/CCL4 mRNA was noted in syngeneic or allogeneic
IPCC grafts compared to the ‘sham’ transplantation (Figure 5A,
5C-E). Only expression of MCP-1/CCL2 mRNA was similarly
low in syngeneic and allogeneic transplanted islets at day 3
(Figure 5C). Moreover, the production of specific ‘inducible
inflammatory’ chemokines at the site of implantation of IPCCs
was reduced in comparison to that following islet transplantation
(Figure 5A, 5B and 5E). In particular, Gro-b/CXCL2 and Lix/
CXCL5 were massively down-regulated in IPCCs compared to
islet grafts in both the syngeneic and allogeneic setting (150-fold
increase for the syngeneic islet group and 504-fold increase for the
allogeneic islet group for Gro-b/CXCL2 and 1000 fold increase in
the syngeneic islet group and 100000 fold in the allogeneic islet
group for Lix/CXCL5) (Figure 5A and 5B). Of the other
chemokines assessed, MIP-1b/CCL4 mRNA was significantly
reduced in IPCCs compared with islets transplanted into
allogeneic recipients at day 3 (Figure 5E). A lower, non-
statistically significant attenuation of MIP-1a/CCL3 mRNA was
also observed in the IPCCs compared with islets transplanted
across the same allogeneic barrier at day 3 (Figure 5D).
Parenthetically, the relative reduction of inflammatory cytokines
and chemokines after IPCC transplantation occurs independently
of heme-oxygenase-1, a stress response protein that alleviates
inflammation and oxidative stress [20] (data not shown). These
data collectively demonstrate that in comparison to islet grafts,
IPCCs induced substantially less inflammatory chemokine expres-
sion after three days of transplantation in the syngeneic and/or
allogeneic setting.
Expression of IP-10/CXCL10, a chemokine associated with
acute graft rejection, was reduced after IPCC
transplantation
The chemokines IP-10/CXCL10 and Mig/CXCL9 are often
associated with acute rejection in transplantation [21] and we
assessed their contribution to the early immune response
following IPCC transplantation. Mig/CXCL9 expression was
similar in IPCC or islet transplantations at day 1 and 3 in either
the syngeneic or allogeneic groups and was not expressed
significantly above the level observed in ‘sham’ transplantation
(data not shown). IP-10/CXCL10 mRNA expression was
similar between the ‘sham’ transplantation, IPCC and islet grafts
at day 1 in the syngeneic and allogeneic groups (Figure 6).
However, on day 3 the IPCC graft expression of IP-10/CXCL10
mRNA was very low compared with that observed in both islet
syngeneic and allogeneic grafts (Figure 6). Incidentally, a
notable increase in IP-10/CXCL10 expression was also observed
between the syngeneic and the allogeneic islet transplants
themselves (Figure 6). Thus, in comparison to islet grafts, IPCC
syngeneic and allogeneic grafts demonstrated reduced expression
of a single chemokine associated with graft rejection in the
incipient stages following transplantation.
Innate Immune Response to ESCs
PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e10965
Figure 3. Attenuated infiltration of innate immune cells across IPCC allogeneic barriers was independent of complement
deposition. (A) 300 IPCCs generated from CBA-derived ES cells or (B) 300 adult pancreatic islets were transplanted under the kidney capsule of
syngeneic (CBA, H2k) or allogeneic (C57 BL/10, H2b) recipient mice and the graft harvested either on day 1 and 3 days post-transplant. Sham
transplantations were also performed. Sections were stained for the complement molecule C3 (red) and counterstained with the DAPI nuclear-dye
Innate Immune Response to ESCs
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Discussion
In this report, we have captured the initial events in the immune
response triggered by the implantation of ESC derived IPCCs.
While an early immune response was observed following IPCC
transplantation, importantly, we also found that ESC derived IPCC
were less immunogenic than their adult pancreatic islet counterparts,
as judged by the attenuated leukocyte infiltration and generation of
specific inflammatory cytokines and chemokines in the first 3 days
after transplantation. That IPCCs show reduced immunostimulatory
capabilities at this stage is further supported by our recent data
showing the absence of up-regulation of the MHC transplantation
antigens at three days following transplantation [13]. In combina-
tion, these data suggest the basis for the relative immune privilege
observed in ESC derived tissue after transplantation [2,13].
Since it is generally accepted that the innate immune system
lacks antigen-specificity, one would expect to observe little
variation between the events triggered by transplantation of
syngeneic and allogeneic IPCCs at these very early time points.
Yet an unexpected, recurring theme in this study was the rapid
involvement of distinct allogeneic responses by 3 days after
transplantation. Our findings are congruent with studies in other
transplantation models [6,22] and may be explained by the
emerging but still under-appreciated concept of cross-talk between
the innate and adaptive immune responses [23,24]. The non-
specific inflammatory response that results from the injury caused
by introducing the graft into the recipient’s body may be
unresolved in the presence of additional immune stimuli, such as
that observed in the transplantation of allogeneic ESC derived
tissue. This idea is supported by our observation of sustained Gr-
1+ and Mac-1+ cell infiltration at 1 week following transplantation
of allogeneic, but not syngeneic IPCCs (A.S.B and K.J.W,
unpublished observations). We posit that this effect may be
mediated by certain effector pathways which bridge the innate and
adaptive immune system [6]. Our study sets the stage for further
investigations into how these two arms of the immune system
conspire to impact ESC derived IPCC transplantation.
So how can we account for the ability of ESC derived IPCCs to
generate less of an early immune response than adult islet grafts in
the allogeneic setting? One explanation is that islets may contain
passenger leukocytes that could activate the direct pathway of
allorecognition [25,26,27]. In contrast, IPCCs are generated in
vitro from ESC and therefore will not share the same potential as
islets for co-transferal of donor-derived leukocytes. Indeed our
studies examining later events involving components of the
adaptive immune system after implantation of IPCCs clearly
demonstrate that priming of an adaptive immune response via the
presentation of allopeptides by host antigen presenting cells, the
so-called indirect pathway of allorecognition, is required before a
T cell response is stimulated [2]. Alternatively, islets may express
more adhesion molecules such as ICAM-1 that can interact with
recipient immune cells enabling them access to the graft site to
intensify inflammation [28].
We found that attenuated infiltration of innate immune cells
across IPCC allogeneic barriers was independent of complement
deposition, as judged by the relative parity in C3 deposition between
IPCCs or islets and ‘sham’ transplantation. The kidney, the site of
IPCC or islet transplantation in this study, is a known producer of
complement in homeostasis and injury [29,30] and this probably
accounts for the robust C3 staining observed in the sham
transplantation setting. That complement deposition was not
differentially enhanced by transplantation of ESC derived IPCCs
(blue) (n = 3 independent experiments at each time point). Photographs were taken using a 40x objective and a 106 eyepiece lens, giving a total
original magnification of6400.
doi:10.1371/journal.pone.0010965.g003
Figure 4. Marked reduction in IL-6 at the early stages following IPCC transplantation. 300 IPCCs generated from CBA-derived ES cells or
300 adult pancreatic islets isolated from CBA mice were transplanted under the kidney capsule of B10 (H2b, allogeneic) and CBA (H2k, syngeneic)
recipients. Intra-graft mRNA expression for the cytokine IL-6, was analysed at days 1 and 3 (n = 629 mice per time point from multiple
differentiations) after transplantation by Q-PCR. Samples were standardised against HPRT. Data shown are the mean 6 SEM and statistical
significance was assessed by unpaired Student’s t test and denoted by an asterisk in the figure.
doi:10.1371/journal.pone.0010965.g004
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or islets reflects the fact that the complement pathway was not
specifically activated in response to transplantation of these tissues.
However, in the longer-term, ESC allografts have been shown to be
susceptible to specific activation of complement [31], which could
be a direct result of the potentiation of this non-specific immune
response by the adaptive immune system [9,32]. Thus, blocking
complement mediated immunogenicity could prove beneficial in
ameliorating non-specific inflammatory graft damage that may be
exacerbated in the presence of IPCC allogeneic tissue [33].
In the syngeneic setting, cellular infiltration and limited
expression of inflammatory cytokines and chemokines was
observed in IPCC grafts by day 3 (see also [13] for intra-graft
IFN-c production after syngeneic IPCC transplantation). These
data broadly support our postulate that early graft damage, at the
level of innate cell and inflammatory immune responses, may play
a pivotal role in the later rejection of IPCCs in syngeneic,
immunocompetent hosts [2]. Our data [2,13] in the syngeneic
transplant background could be pertinent when considering the
use of immune matched induced pluripotent stem (iPS) cells in cell
replacement therapy; iPS cells may also be subject to similar
mechanisms of damage and, ultimately, rejection after transplan-
tation even though, a priori, they should be histocompatible. For
example, will iPS cells that have been differentiated to a specific
tissue express immunogenic antigens that mark the graft for
rejection? This is a salient issue as even minor antigen mismatches
are sufficient to induce ESC graft rejection [12]. Also, how will iPS
graft functionality be impaired by the infiltration of neutrophils
and macrophages following transplantation? These and other
associated issues warrant further evaluation.
In closing, our study suggests a potential basis for the relative
immune privilege exhibited by fully differentiated ESC derived
IPCCs [2,13]. Our data also offer insights into the eminently
targetable pathways that may be used to obviate the graft rejection
that occurs following IPCC transplantation [2]. In this respect, it is
interesting to speculate that early and sustained targeting of the
innate immune system, inflammatory cytokines and/or chemokine
pathways identified here may provide a specific means to achieve
ESC derived IPCC graft acceptance.
Figure 5. The expression of specific inflammatory chemokines was either absent or sharply reduced at the early stages after
syngeneic or allogeneic IPCC transplantation. 300 IPCCs generated from CBA-derived ES cells or 300 adult pancreatic islets isolated from CBA
mice were transplanted under the kidney capsule of B10 (H2b, allogeneic) and CBA (H2k, syngeneic) recipients. Intra-graft mRNA expression for
inflammatory chemokines (A) Gro-b/CXCL2, (B) LIX/CXCL5, (C) MCP-1/CCL2, (D) MIP-1a/CCL3 and (E) MIP-1b/CCL4 were analysed at days 1 and 3
(n = 629 mice per time point from multiple differentiations) after transplantation by Q-PCR. Samples were standardised against HPRT. Data shown are
the mean 6 SEM and statistical significance was assessed by unpaired Student’s t test and denoted by an asterisk in the figure.
doi:10.1371/journal.pone.0010965.g005
Innate Immune Response to ESCs
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Supporting Information
Figure S1 Scheme for directed differentiation of ES cells to
insulin-producing cell clusters. Starting post-embryoid body
(EB) generation, hanging drop cultures (not shown) were
inverted and the plate flooded with medium to suspend the
EBs. 5 days after, the cells were replated onto gelatin-coated
dishes for another 7 days culture in basic ES cell medium
(knock-out (KO-) DMEM (Invitrogen, Paisley, Scotland), 15%
FCS, 1% 100 microM L-glutamine, 1% non-essential amino
acids (non-eAAs) (all Invitrogen), 1% 100 micoM penicillin-
streptomycin and 100 microM beta-ME). The cell clusters
were transferred onto dishes coated with poly-L-ornithine
(PLO) and laminin in B2 medium, made up in DMEM: F12
(1:1) plus N2 supplement (Sigma) and B27 supplement (Sigma).
The cells were expanded in this medium for 19 days and were
harvested at this point. Refer to Boyd et al., 2008 for further
detailed information.
Found at: doi:10.1371/journal.pone.0010965.s001 (0.01 MB
PDF)
Figure S2 Experimental model used to investigate the early
immune response that may arise after transplantation of either
IPCCs or pancreatic islets in mice. IPCCs were generated using
ESF 122 ES cells using the modified Blyszczuk protocol (See
Figure S1). 300 IPCCs or 300 pancreatic islets isolated from CBA
mice were transplanted under the kidney capsule of syngeneic
(CBA, H2k) or allogeneic BL/10, H2b) recipient mice and the
grafts excised on day 1 or 3 days post-transplant. Half the graft was
taken for immunofluorescence and half to analyse intra-graft gene
expression by Q-PCR.
Found at: doi:10.1371/journal.pone.0010965.s002 (0.45 MB
PDF)
Figure S3 The spleen is a source of Gr1+ and Mac1+ cells. In
the study, spleen sections were used as a positive control for
staining of Gr-1 and Mac-1 as the spleen is known to contain
neutrophils and macrophages within the area called red pulp,
labelled R in panel A. Staining of Gr-1 within the red pulp was
evident at x100 (A) and x400 (B) original magnifications (original
magnification calculated from use of a 10x eyepiece and a 40x
objective lens). The area of the photograph labelled W in panel A
corresponds to the T and B cell zone of the spleen, also called the
white pulp. An arrow in B points to a close up of a Gr-1+ cell with
a multi-lobed nucleus. Mac-1 staining can also be seen clearly at
x10 (C) and x40 (D) original magnifications. These photographs
are representative of n= 8 experiments.
Found at: doi:10.1371/journal.pone.0010965.s003 (0.31 MB
PDF)
Table S1 Primer sequences for SYBR Green Q-PCR.
Found at: doi:10.1371/journal.pone.0010965.s004 (0.03 MB
DOC)
Table S2 Primer sequences for TaqMan Q-PCR.
Found at: doi:10.1371/journal.pone.0010965.s005 (0.03 MB
DOC)
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Figure 6. IP-10/CXCL10, a chemokine associated with acute graft rejection, was reduced immediately following IPCC
transplantation. 300 IPCCs generated from CBA-derived ES cells or 300 adult pancreatic islets isolated from CBA mice were transplanted under
the kidney capsule of B10 (H2b, allogeneic) and CBA (H2k, syngeneic) recipients. Intra-graft mRNA expression of a chemokine associated with rejection
IP-10/CXCL10 was analysed at days 1 and 3 (n = 629 mice per time point from multiple differentiations) after transplantation by Q-PCR. Samples were
standardised against HPRT. Data shown are the mean6 SEM and statistical significance was assessed by unpaired Student’s t test and denoted by an
asterisk in the figure.
doi:10.1371/journal.pone.0010965.g006
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